Cargando…

Alterations of oncogenes expression in NK cells in patients with cancer

INTRODUCTION: C‐kit/SCF signaling plays a key role in regulating NK cell homeostasis, maturation, proliferation, and cytotoxicity. C‐kit‐deficiency in NK cells results in significant reduction of their number, suggesting an imperative role for c‐kit signaling in NK cell biology. We have recently sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakiryanova, Gulnur K., Kustova, Elena, Urazalieva, Nataliya T., Amirbekov, Aday, Baimuchametov, Emile T., Nakisbekov, Narymzhan N., Shurin, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691306/
https://www.ncbi.nlm.nih.gov/pubmed/28695716
http://dx.doi.org/10.1002/iid3.179
_version_ 1783279769829244928
author Zakiryanova, Gulnur K.
Kustova, Elena
Urazalieva, Nataliya T.
Amirbekov, Aday
Baimuchametov, Emile T.
Nakisbekov, Narymzhan N.
Shurin, Michael R.
author_facet Zakiryanova, Gulnur K.
Kustova, Elena
Urazalieva, Nataliya T.
Amirbekov, Aday
Baimuchametov, Emile T.
Nakisbekov, Narymzhan N.
Shurin, Michael R.
author_sort Zakiryanova, Gulnur K.
collection PubMed
description INTRODUCTION: C‐kit/SCF signaling plays a key role in regulating NK cell homeostasis, maturation, proliferation, and cytotoxicity. C‐kit‐deficiency in NK cells results in significant reduction of their number, suggesting an imperative role for c‐kit signaling in NK cell biology. We have recently showed that human NK cells express not only c‐kit‐receptor, but also both membrane‐bound and soluble forms of c‐kit ligand—Stem cell factor. The goal of this study was to characterize the c‐kit/SCF autocrine loop in peripheral blood NK cells obtained from patients with cancer. METHODS: Using Smart Flare and qRT‐PCR, we have characterized expression of c‐kit and two forms of SCF in patients’ NK cells and correlated these results with the expression of c‐myc and STAT3. RESULTS: Our results demonstrated that the expression of proto‐oncogenes c‐myc and c‐kit was significantly decreased in NK cells from all cancer patients. Expression of membrane‐bound SCF in NK cells correlated with the presence of remote metastases. CONCLUSIONS: We suggest that the abnormal signaling and expression of c‐kit/SCF, c‐myc, and STAT3 in NK cells is responsible for the defect in their cytolytic activity in cancer and these defects at the gene expression level may be the cause rather than the result of tumor progression.
format Online
Article
Text
id pubmed-5691306
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56913062017-11-24 Alterations of oncogenes expression in NK cells in patients with cancer Zakiryanova, Gulnur K. Kustova, Elena Urazalieva, Nataliya T. Amirbekov, Aday Baimuchametov, Emile T. Nakisbekov, Narymzhan N. Shurin, Michael R. Immun Inflamm Dis Original Research INTRODUCTION: C‐kit/SCF signaling plays a key role in regulating NK cell homeostasis, maturation, proliferation, and cytotoxicity. C‐kit‐deficiency in NK cells results in significant reduction of their number, suggesting an imperative role for c‐kit signaling in NK cell biology. We have recently showed that human NK cells express not only c‐kit‐receptor, but also both membrane‐bound and soluble forms of c‐kit ligand—Stem cell factor. The goal of this study was to characterize the c‐kit/SCF autocrine loop in peripheral blood NK cells obtained from patients with cancer. METHODS: Using Smart Flare and qRT‐PCR, we have characterized expression of c‐kit and two forms of SCF in patients’ NK cells and correlated these results with the expression of c‐myc and STAT3. RESULTS: Our results demonstrated that the expression of proto‐oncogenes c‐myc and c‐kit was significantly decreased in NK cells from all cancer patients. Expression of membrane‐bound SCF in NK cells correlated with the presence of remote metastases. CONCLUSIONS: We suggest that the abnormal signaling and expression of c‐kit/SCF, c‐myc, and STAT3 in NK cells is responsible for the defect in their cytolytic activity in cancer and these defects at the gene expression level may be the cause rather than the result of tumor progression. John Wiley and Sons Inc. 2017-07-10 /pmc/articles/PMC5691306/ /pubmed/28695716 http://dx.doi.org/10.1002/iid3.179 Text en © 2017 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Zakiryanova, Gulnur K.
Kustova, Elena
Urazalieva, Nataliya T.
Amirbekov, Aday
Baimuchametov, Emile T.
Nakisbekov, Narymzhan N.
Shurin, Michael R.
Alterations of oncogenes expression in NK cells in patients with cancer
title Alterations of oncogenes expression in NK cells in patients with cancer
title_full Alterations of oncogenes expression in NK cells in patients with cancer
title_fullStr Alterations of oncogenes expression in NK cells in patients with cancer
title_full_unstemmed Alterations of oncogenes expression in NK cells in patients with cancer
title_short Alterations of oncogenes expression in NK cells in patients with cancer
title_sort alterations of oncogenes expression in nk cells in patients with cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691306/
https://www.ncbi.nlm.nih.gov/pubmed/28695716
http://dx.doi.org/10.1002/iid3.179
work_keys_str_mv AT zakiryanovagulnurk alterationsofoncogenesexpressioninnkcellsinpatientswithcancer
AT kustovaelena alterationsofoncogenesexpressioninnkcellsinpatientswithcancer
AT urazalievanataliyat alterationsofoncogenesexpressioninnkcellsinpatientswithcancer
AT amirbekovaday alterationsofoncogenesexpressioninnkcellsinpatientswithcancer
AT baimuchametovemilet alterationsofoncogenesexpressioninnkcellsinpatientswithcancer
AT nakisbekovnarymzhann alterationsofoncogenesexpressioninnkcellsinpatientswithcancer
AT shurinmichaelr alterationsofoncogenesexpressioninnkcellsinpatientswithcancer